期刊文献+

萘骈苯骈吡喃酮类活性化合物研究进展

原文传递
导出
摘要 萘骈苯骈吡喃酮是一类由萘环和苯环分别在α,β-和γ,δ-稠合的六元不饱和内酯类化合物,多数与糖形成C-苷或O-苷;此类化合物具有良好的细胞毒或抗菌活性。迄今为止,报道了49个此类化合物,涉及26篇文献。本文综述了这49个萘骈苯骈吡喃酮类化合物的结构、生物和化学来源及其生物活性。表明链霉菌是萘骈苯骈吡喃酮类化合物的主要来源,已从链霉菌的次生代谢产物中分离鉴定了31个天然的萘骈苯骈吡喃酮类化合物;其良好的生物活性吸引化学家对其进行结构修饰和改造,得到了18个化学衍生物,其中1个已进入治疗乳腺癌的II期临床研究;萘骈苯骈吡喃酮可能是一类重要的抗肿瘤或抗菌药物先导化合物。
出处 《中国海洋药物》 CAS CSCD 北大核心 2012年第5期52-58,共7页 Chinese Journal of Marine Drugs
基金 国家高技术研究发展计划项目(2012AA092104) 国家自然科学基金项目(21172204 21002094) 山东省自然科学基金项目(ZR2009CQ014)资助
  • 相关文献

参考文献31

  • 1陈敏捷,王广华,戴世鲲,谢练武,李翔.链霉菌聚酮类次生代谢产物及其生物合成基因簇[J].微生物学报,2009,49(12):1555-1563. 被引量:3
  • 2李欧,缪克排.链霉菌次级代谢研究进展[J].中国抗生素杂志,2005,30(11):695-698. 被引量:15
  • 3傅俊曾,冀兰鑫,谢春锋.链霉菌属微生物来源的生物活性天然产物[J].药物评价研究,2010,33(2):153-158. 被引量:11
  • 4Leach B E, Calhoun K M, Johnson L E, et al. Chartreusin, a new antibiotic produced by Streptornyces chartreusis, a new species[J]. JAm Chem Soc, 1953, 75(16): 4011.
  • 5Nakano H, Matsuda Y, Ito K, et al. Gilvocarcins, new antitumor antibiotics. 1. Taxonomy, fermentation, isolation and biological activities[J]. J Antibiot, 1981, 34(3): 266.
  • 6Morimoto M, Okubo S, Tomita F, et al. Gilvocarcins, new antitumor antibiotics. 3. Antitumor activity[J]. J Antibiot, 1981, 34(6): 701.
  • 7Balitz D M, Herron F A, Bush J, et al. Antitumor agents from Streptomyces anandii: Gilvocareins V, M and E[J]. J Antibiot, 1981, 34(12): 1544.
  • 8Takahashi K , Tomita F. Gilvocarcins, new antitumor anti biotics. 5. Biosynthesis of gilvocarcins: incorporation of ^13C- labeled compounds into gilvocarcin aglycones[J]. J Antibiot, 1983,36(11): 1531.
  • 9Renuka M, Harold R T, Ramesh C P. Defucogilvocarcin V, a new antibiotic from Streptomyces arenae 2064: isolation, characterization, partial synthesis and biological activity[J]. J Antibiot, 1985, 38(9): 1280.
  • 10Lawreence R M, Renuka M. Gilvocarcin photobiology. Isolation and characterization of the DNA photoadduct[J]. J Am Chem Soc, 1990, 112(6): 2386.

二级参考文献69

  • 1吴雪昌,汪志芸,周婕,朱旭芬,钱凯先.提高产抗生素链霉菌紫外诱变正变率的研究[J].遗传,2004,26(4):499-504. 被引量:8
  • 2徐平,李文均,高慧英,徐丽华,姜成林.聚酮类化合物生物合成途径基因阳性菌株生物多样性研究[J].微生物学报,2005,45(6):821-827. 被引量:17
  • 3Kim SB, Lonsdale J, Seong CN, et al. Streptacidiphilus gen. nov., acidophilic actinomycetes with wall chemotype I and emendation of the family Streptomycetaceae (Waksman and Henrici (1943) AL) emend. Rainey et al. 1997. Antonie Van Leeuwenhoek, 2005, 83(2) : 107 - 116.
  • 4Park CN, Lee JM, Lee D, et al. Antifungal activity of valinomycin, a peptide antibiotic produced by Streptomyces sp. Strain M10 antagonistic to Botrytis cinerea. Journal of Microbiology and Biotechnology, 2008, 18(5) : 880 - 884.
  • 5Wang L, Yun BS, George NP, et al. Glycopeptide antitumor antibiotic zorbamycin from Streptomyces flavoviridis ATCC 21892: strain improvement and structure elucidation. Journal of Natural Products, 2007, 70 ( 3 ) : 402 - 406.
  • 6Watanabe K, Praseuth AP, Wang CC. A comprehensive and engaging overview of the type m family of polyketide synthases. Current Opinion in Chemical Biology, 2007, 11 (3) : 279 - 286.
  • 7Staunton J, Weissman KJ. Polyketide biosynthesis : millennium review. Natural Product Reports, 2001, 18(4) : 380 - 416.
  • 8Hertweck C, Luzhetskyy A, Rebets Y, et al. Type Ⅱ polyketide synthases: gaining a deeper insight into enzymatic teamwork. Natural Product Reports, 2007, 24(1): 162- 190.
  • 9Gokhale RS, Sankaranarayanan R, Mohanty D. Versatility of polyketide synthases in generating metabolic diversity. Current Opinion Structural Biology, 2007, 17 (6) : 736 - 743.
  • 10Rascher A, Hu Z, Buchanan GO, et al. Insights into the biosynthesis of the benzoquinone ansamycins geldanamycin and herbimycin, obtained by gene sequencing and disruption. Applied Environmental Microbiology, 2005, 71 (8) : 4862 -4871.

共引文献26

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部